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Abstract
Introduction: To determine the validity and reliability of patients’ self-performed joint counts compared to joint
counts by professional assessors in rheumatoid arthritis (RA) patients in different disease activity states.
Methods: In patients with established RA we determined the inter-rater reliability of joint counts performed by an
independent evaluator and the patient using intraclass correlation (ICC), and agreement on activity in individual
joints by kappa statistics. We also performed longitudinal analyses to assess consistency of assessments over time.
Finally, we investigated the concordance of joint counts of different assessors in patients with different levels of
disease activity.
Results: The reliability of patient self-performed joint counts was high when compared to independent objective
assessment (ICC; 95%confidence interval (CI)) for the assessment of swelling (0.32; 0.15 to 0.46) and tenderness
(0.75; 0.66 to 0.81), with higher agreement for larger joints (kappa: 0.57 and 0.45, respectively) compared to smaller
joints (metacarpo-phalangeal joint (MCPs): 0.31 and 0.45; and proximal interphalangeal joint (PIPs): 0.22 and 0.47,
for swelling and tenderness, respectively).
Patients in remission according to the Simplified Disease Activity Index (SDAI ≤ 3.3) showed better concordance of
the joint counts (swollen joint count (SJC) ties 25/37, tender joint count (TJC) ties 26/37) compared to moderate/
high disease activity states (SDAI > 11; MDA/HDA: SJC ties 9/72, TJC ties 21/72). Positive and negative predictive
values regarding the presence of SDAI remission were reasonably good (0.86 and 0.95, respectively). A separate
training session for patients did not improve the reliability of joint assessment. The results were consistent in the
longitudinal analyses.
Conclusions: Self-performed joint counts are particularly useful for monitoring in patients having attained
remission, as these patients seem able to detect state of remission.
Introduction
Rheumatoid arthritis is a chronic disease characterized by
an inflammatory process which, over time, leads to irre-
versible joint destruction. This joint damage is unequivo-
cally related to the clinical involvement of the joints [1,2];
therefore, assessment of joint involvement by examining
their swelling and tenderness is crucial in RA. Formal
joint assessments, so called joint counts, are generally
performed by physicians, nurses or other health profes-
sionals. Measures of joint activity regarding swelling and
tenderness are also part of most composite disease activ-
ity indices in RA.
In recent years, formal disease activity assessment has
moved into the focus of RA management [3] and new
treatment strategies have been brought forward suggest-
ing that remission may be one of the main targets in
treating RA [4]. The state of remission is superior to
other disease activity states, including low disease activ-
ity, with regard to structural, functional, and economic
outcomes [5,6]. This is also reflected in the 2010
European League against Rheumatism (EULAR) man-
agement recommendations for RA, which suggest con-
stant evaluations and rapid treatment adaptations until
the goal of remission is reached [4].
However, a close and accurate assessment of disease
activity is time consuming and, as many clinics are
facing limited outpatient capacity, physicians are often
reluctant to perform complete joint counts and are also
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forced to reduce the frequency of their patients’ routine
visits once their arthritis has improved. Also, since the
ultimate goal is not only reaching but rather maintain-
ing remission for long term, it is necessary to monitor
patients closely to control for persistence of remission.
Nevertheless, candidates for reductions in outpatient
contacts would be patients in remission rather than
those with active disease who, from a medical perspec-
tive, require more intensive attention. This is also
reflected in the treat-to-target recommendations [7]
where it is suggested that patients with active disease
should be seen monthly while for patients in remission
control examinations are recommended every six
months or less frequently. However, these patients still
require monitoring of disease activity, since the risk of
flares remains, even while continuing therapy [8].
Although the term flare has not yet been well defined,
the recurrence of clinical joint activity is most likely an
indicator of such a flare. Patients may be scheduled for a
clinic or office visit at another time point than that
around recurrence of inflammatory joint activity, and the
time elapsing until that scheduled visit may allow for
significant damage to occur or may make the flare more
difficult to manage. However, if patients could monitor
their own joints for swelling, they could alert their rheu-
matologist for an immediate clinic appointment.
Several studies have addressed patient self assessed
swollen and tender joint counts as well as their correla-
tion with evaluator derived joint counts [9]; the results of
these studies are controversial, partially concluding that
patient derived joint counts are simply not accurate
enough. None of these studies, however, looked sepa-
rately at patients in different states of disease activity,
especially in remission.
In the present study, we, therefore, were interested to
evaluate the reliability of self-assessed joint counts among
RA patients, but aimed to focus on patients in different
disease activity states including remission to investigate if
sensitivity for joint activity of self-performed joint counts
changes with the extent of disease activity. We hypothe-
sized that the reliability of self-assessed joint counts would
increase with decreasing disease activity which, if proven,
would allow scheduling RA patients’ visits in remission at
longer intervals, while they could monitor the mainte-
nance of remission on a more frequent basis at home. We




A total of 209 consecutive RA patients, routinely visiting
our outpatient department were randomly recruited into
the study; all patients who were included provided
informed consent. No further inclusion or exclusion cri-
teria applied. The study was approved by the Ethics Com-
mittee of the Medical University of Vienna.
Traditional 28-joint counts were performed for swel-
ling and tenderness by the patient, a biometrician, and a
rheumatologist. After the participants had performed
and documented their self- assessment, tender and swol-
len joint counts were determined by a biometrician, a
trained health professional performing joint counts reg-
ularly at our clinic, and a rheumatologist, who was not
involved in treatment decisions. Patients, biometrician,
and the physician were blinded to each other’s results,
and patients were advised not to discuss their assess-
ment with the other assessors. In addition, routine clini-
cal and laboratory measurements, such as the health
assessment questionnaire (HAQ), C-reactive protein
(CRP) and erythrocyte sedimentation rate (ESR), were
also collected; composite indices, such as the clinical
disease activity index (CDAI), simplified disease activity
index (SDAI) and disease activity score using 28 joints
(DAS28), were calculated. The biometrician’s joint
counts were used as the gold standard, since their
assessment is the documented routine procedure in our
clinic. The whole process was repeated at a subsequent
clinical visit three months later, to allow assessment of
longitudinal reliability.
Patient instructions
Patients were pseudo-randomly allocated to two groups in
a 2:1 manner: consecutive patients who gave informed
consent visiting our department on odd calendar days
received formal joint count training by a physician,
whereas patients visiting on even days remained untrained.
Those on even days (n = 131) were merely instructed to
mark the tender and swollen joints in two respective draw-
ings presenting 28 joints, based on their own joint assess-
ment for swelling and tenderness (Figure 1). On odd days
(n = 78) patients received a short training session with a
special emphasis on the explanation of joint swelling in
terms of soft tissue (synovial) versus bony swelling. After-
wards patients were instructed to put their marks on the
simple, structured questionnaires. The randomization pro-
cess was performed by the first author who was not
involved in the assignment of visit date.
Cross sectional analysis
Two-way comparisons of the joint count results
obtained by the three assessors were performed using an
intraclass correlation coefficient (ICC) for the count (0
to 28), as well as Kappa statistics for each individual
joint and joint region. To assess the value of the struc-
tured training session, we also compared correlations of
trained and untrained patients using ICC to determine
Radner et al. Arthritis Res Ther 2012, 14:R61
http://arthritis-research.com/content/14/2/R61
Page 2 of 9
whether simple training can improve the correlation
between patient and independent assessor.
Longitudinal analysis
Longitudinal assessments were used to determine
whether changes in joint counts observed over the three
month period were consistent among the different asses-
sors (correlation of changes) and to test whether
patients improve their ability to assess joint swelling and
tenderness (Wilcoxon-Test).
Validity of self assessed joint counts in different disease
activity states
Next, patients were divided according to the levels of
disease activity by SDAI and inter-rater-reliability was
assessed in three different subgroups, remission (REM,
Figure 1 Joint count questionnaire for swelling, similar questionnaire was filled in for tenderness.
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SDAI < 3.3), low disease activity (LDA, 3.3 < SDAI < 11)
and moderate to high disease activity (MDA/HDA,
SDAI > 11). We then repeated the cross sectional ana-
lyses as outlined above in the three subgroups to assess
differences according to disease activity levels.
Validity of self assessed joint counts in determining the
presence of remission
Concordance of remission rates was compared using
either patient self-assessed joint counts or joint counts
performed by a physician or biometrician. Remission was
defined according to new American College of Rheumatol-
ogy (ACR)/EULAR Remission Criteria [7] using the Boo-
lean criteria as swollen joint count (SJC) < 1, tender joint
count (TJC) < 1, patient global assessment of disease activ-
ity (PGA) < 1 cm with and without CRP < 1 mg/dl and the
index-based criteria, SDAI (≤ 3.3) and CDAI (≤ 2.8).
This study was approved by the Ethics Committee of
the Medical University of Vienna. The Statistical Pack-
age for the Social Sciences (SPSS, Version 17) was used
for the conduct of the analyses.
Results
In total, our cohort comprised 209 patients with estab-
lished RA, who were randomly selected at our clinic. Base-
line characteristics are shown in Table 1. Regarding
treatment strategies, in total 4.8% did not receive any
disease modifying anti-rheumatic drug (DMARD) due to
different reasons (remission, pregnancy), 63.6% of patients
received synthetic DMARDs, and 31.6% received biological
agents with or without synthetic DMARDs. We found no
significant differences of distribution of treatment strate-
gies within trained and untrained patients or within differ-
ent levels of disease activity.
Cross sectional analysis of inter-rater variability
Using ICC we found significant consistency of patient
derived joint counts with those of the two independent
observers (P < 0.003) (Table 2) at both visits.
Consistency of physician and biometrician derived joint
counts served as a benchmark for the interpretation of
the validity of patient derived joint counts, showing high
concordance (P < 0.001). Due to the high concordance of
physician and biometrician joint counts, we used the bio-
metrician derived joint counts as the gold standard
reference.
Effect of the structured patient training session
Comparing the correlations of patient and observer
derived joint counts between the trained and the
untrained patient groups, we found no noteworthy differ-
ences: looking at the baseline assessments, in the
Table 1 Baseline characteristics of included patients.
P-value
Baseline characteristics TOTAL TRAINED UNTRAINED trained vs. untrained
Number 209 78 131
Female 80.4% 79.5% 80.9%
Rheumatoid factor pos. 55.5% 52.6% 57.3%
Age (years) 56.3(12.3) 54.2 (12.6) 57.6 (12.0) 0.06
Disease duration (years) 11.4 (9.6) 11.0 (9.2) 11.6 (9.9) 0.66
PGA (mm) 28.1 (21.9) 28.1 (22.4) 28.0 (21.7) 0.97
VAS pain (mm) 26.2 (21.0) 26.1 (20.9) 26.2 (21.2) 0.99
EGA (mm) 12.9 (13.5) 16.3 (15.7) 10.8 (11.5) 0.004
CRP (mg/dl) 0.92 (2.0) 1.0 (1.7) 0.89 (2.2) 0.81
ESR (mm/hr) 26.2 (22.3) 28.2 (26.1) 25.1 (20.1) 0.38
HAQ 0.78 (0.72) 0.81 (0.74) 0.77 (0.71) 0.71
SJC28 biometrican 2.4 (3.0) 3.3 (3.3) 1.9 (2.7) 0.001
TJC28 biometrican 2.7 (4.5) 2.4 (4.1) 2.9 (4.7) 0.48
SJC28 physician 2.4 (1.9) 3.1 (3.1) 1.9 (2.7) 0.004
TJC28 physician 3.0 (4.1) 2.9 (3.7) 3.0 (4.4) 0.85
SJC28 patient 3.1 (4.3) 2.7 (3.6) 3.4 (4.7) 0.28
TJC28 patient 3.4 (5.2) 3.0 (4.5) 3.7 (5.6) 0.33
CDAI 9.0 (7.4) 10.1 (7.9) 8.4 (7.0) 0.097
SDAI 10.0 (7.8) 11.1 (8.5) 9.3 (7.4) 0.094
DAS28 3.4 (1.1) 3.4 (1.2) 3.4 (1.1) 0.33
Data are shown as mean (SD) unless indicated otherwise.
CDAI: Clinical Disease Activity Index, CRP: c-reactive protein, DAS28: disease activity score 28, EGA: evaluator global assessment of disease activity, ESR:
erythrocyte sedimentation rate, HAQ: health assessment questionnaire, PGA: patient global assessment of disease activity, SDAI: simplified disease activity score,
SJC28: swollen joint count, TJC28: tender joint count, VAS: pain visual analogue scale of pain
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untrained group the ICC was 0.32 (0.15 to 0.46) for
SJC28 and 0.75 (0.66 to 0.81) for TJC28; for the trained
group, the ICC was 0.35 (0.14 to 0.53) for SJC28 and 0.59
(0.42 to 0.72) for TJC28. Similar results were obtained for
the follow up visit (data not shown).
As a consequence of these data, we pooled the two
groups of trained and untrained patients for the more
detailed analyses to follow.
Validity of patient self-assessed joint counts by joints and
joint regions
Using Kappa statistics in all 209 patients, we analyzed the
agreement between the two assessors (patient and biome-
trician) at the baseline visit by individual joints and joint
region. A non-significant agreement was found for three
small joints (left metacarpophalangeal joint I (MCP I),  =
0.13; left proximal interphalangeal joint V (PIP V),  =
0.13; right interphalangeal joint (IP),  = 0.05). In general
the small joints of the right hand tended to show better
correlation with the biometrician derived joint count com-
pared with those of the left hand (mean kappa right hand
= 0.31; left hand = 0.23; T-test P = 0.09) (Figure 2). Kappa
also differed when calculated for the various joint regions
or types: 0.23 for swelling of large joints (shoulders, knees
and elbows), 0.45 for tenderness of large joints; 0.31 and
0.45 for swelling and tenderness of MCPs, respectively;
0.22 and 0.47 for PIPs; and 0.31 and 0.45, respectively, for
swelling and tenderness of the total hand (MCPs, PIPs and
wrists). In summary, we found a consistently superior
agreement of joint tenderness compared to joint swelling.
Follow up assessment and longitudinal analyses
Three months after the initial visit, 144 of the 209
patients (69%; 57 trained, 87 untrained) were re-assessed
for their joint activity in a similar manner. We found sig-
nificant consistency between patient and observer joint
counts (again biometrician data were used; Table 2) at
the follow up visit compared to the baseline visit: SJC
0.38 (0.23 to 0.51) versus 0.30 (0.18 to 0.42); TJC 0.71
(0.62 to 0.79) versus 0.70 (0.62 to 0.76).
To investigate whether discrepancies in joint assessment
were consistent over time we used ICC, correlating differ-
ences between patient and observer derived joint counts at
baseline with those at follow up; these analyses showed
that the discrepancy was similar over time, that is, a good
correlation of discrepancy at the two time points, ICC
(95% confidence interval (CI)) SJC = 0.56 (0.44 to 0.66);
TJC = 0.36 (0.21 to 0.50) (P < 0.001).
We further used ICC calculations to compare whether
changes of joint counts assessed by patients were
Table 2 Intraclass correlation of different observer derived joint counts at baseline and follow up visit.





Patient derived Joint counts Baseline Follow-up Baseline Follow-up
TOTAL N = 209 N = 144 N = 209 N = 144
Swollen Joint Count 28 0.30 (0.18- 0.42) 0.38 (0.23-0.51) 0.35 (0.22-0.46) 0.43 (0.28-0.55)
Tender Joint Count 28 0.70 (0.62-0.76) 0.71 (0.62-0.79) 0.80 (0.74-0.84) 0.82 (0.76-0.87)
UNTRAINED PATIENTS N = 131 N = 87 N = 131 N = 87
Swollen Joint Count 28 0.32 (0.15-0.46) 0.33 (0.13-0.51) 0.39 (0.23-0.52) 0.41 (0.22-0.57)
Tender Joint Count 28 0.75 (0.66-0.81) 0.72 (0.60-0.81) 0.85 (0.80-0.90) 0.81 (0.72-0.87)
TRAINED PATIENTS N = 78 N = 57 N = 78 N = 57
Swollen Joint Count 28 0.35 (0.14-0.53) 0.50 (0.28-0.67) 0.33 (0.12-0.51) 0.48 (0.25-0.66)
Tender Joint Count 28 0.59 (0.42-0.72) 0.72 (0.56-0.82) 0.66 (0.51-0.77) 0.84 (0.74-0.90)
Physician derived Joint counts Baseline Follow-up
Swollen Joint Count 28 0.95 (0.93-0.96) 0.90 (0.87-0.93) 1 1
Tender Joint Count28 0.86 (0.82-0.89) 0.89 (0.85-0.92) 1 1
Figure 2 Correlation between patient and biometrician derived
joint counts showing kappa values of individual joints.
Radner et al. Arthritis Res Ther 2012, 14:R61
http://arthritis-research.com/content/14/2/R61
Page 5 of 9
concordant with changes observed by the independent
assessor. This showed a low but significant (P = 0.02)
correlation of change of SJC (ICC = 0.17; 0.01 to 0.33)
and TJC (ICC = 0.35; 0.2 to 0.48; P < 0.01).
Validity of self assessed joint counts in different disease
activity states
Looking at the numerical differences of swollen and tender
joint count, we found a mean difference of 2.6 (+ 3.6)
joints for swelling and 2.0 (+ 3.3) for tenderness between
patient and observer derived joint counts. Importantly, the
discordance increased with the overall number of involved
joints (Figure 3), showing a significant correlation (P <
0.01) between the numerical difference of swollen and ten-
der joint count with SJC28 (r = 0.49) or respective TJC28
(r = 0.46).
Based on these findings and in line with our main
hypothesis, we next performed the analyses in subgroups
of patients in different states of disease activity according
to SDAI (REM, n = 37; LDA, n = 100; and MDA/HAD,
n = 72). Significant differences between the three sub-
groups for the mean divergences of patient and observer
derived joint counts were found, namely a lower discre-
pancy for patients in REM compared with those in LDA,
MDA/HDA (mean differences + SD, SJC: REM = 0.32 +
0.47; LDA = 2.0 + 2.3; MDA/HDA = 4.5 + 4.8, P < 0.001);
TJC: REM = 0.38 + 0.68; LDA = 1.8 + 3.0; MDA/HDA =
3.1 + 4.0, P < 0.001;
Using Spearman correlation, we investigated which vari-
ables might influence the discordance and found a
significant correlation of HAQ (r = 0.23), visual analogue
score (VAS) for pain (r = 0.27), disease duration (r = 0.16)
and SDAI (r = 0.55) with the mean discrepancy of swollen
joint counts; and HAQ (r = 0.32), VAS pain (r = 0.39) and
SDAI (r = 0.38) with discrepancy of tender joint counts. In
a general linear model accounting for these variables we
could show a linear increase of discrepancy of tender and
swollen joint counts with increasing disease activity (mean
differences (95%CI): SJC: REM = 0.68 (-0.5 to 1.9); LDA =
2.1 (1.5 to 2.8); MDA/HDA = 4.4 (3.5 to 5.3) P < 0.001;
TJC: REM = 0.9 (-0.2 to 2.0); LDA = 2.0 (1.4 to 2.6);
MDA/HDA = 3.1 (1.7 to 3.4) P < 0.001)
Using the Wilcoxon test, we found a high concor-
dance of the joint counts obtained by patients and
observer among patients in REM (SJC ties 25/37, TJC
ties 26/37) whereas in LDA or MDA/HDA there was
only a low frequency of exact matches (LDA: SJC ties
25/100, TJC ties 34/100; MDA/HDA: SJC ties 9/72, TJC
ties 21/72).
Thus, since the major prerequisite for monitoring dis-
ease activity using patient self-assessed joint counts
ought to be a high sensitivity compared to the assess-
ment by a health professional, self-evaluation of swollen
and tender joints should only be performed by patients
in REM or at most LDA.
Self assessed joint counts in determining the presence of
remission
Table 3 shows the consistency of fulfilling the new
ACR/EULAR Remission Definitions [7] when patient or
Figure 3 Discordance of joint assessment is dependent on overall number of active joints. Bland-Altman-Plot for patient and biometrician
joint counts, plotting the differences of their joint counts (y-axis) against the mean of the joint counts (x-axis). The discordance of assessment
increases with higher number of affected joints.
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biometrician joint assessments are used. The positive
predictive value (PPV) of patient assessed remission for
the different options suggested by the ACR/EULAR as
the gold standard ranged between 0.71 and 0.86, the
negative predictive value was even higher (0.85 to 0.95;
Table 3).
Discussion
In this study we demonstrated that self assessed joint
counts may be very useful in patients with RA who have
very low levels of disease activity. This becomes especially
important in the conflict between calls for tight control of
RA on the one hand [3,4,13] and availability of resources
on the other: accurate assessment especially of swollen
and tender joints is time consuming and as physicians are
facing a higher number of patients in routine care, patient
self derived joint counts may constitute a helpful tool to
allow for frequent assessment of disease activity without
consuming health care capacities.
Several published studies showed different levels of
agreement between patient and objective assessor derived
joint counts. Our results suggest an overall moderate
agreement of patient and observer derived joint counts,
as expected from the literature [10-12]. Higher agree-
ment was observed for the assessment of joint tenderness
compared to joint swelling, also consistent with findings
of previously reported studies [11]. Importantly, however,
the finding that the agreement improves as the number
of affected joints decreases is novel and may have crucial
corollaries: when we specifically looked at patients
in REM we found a very low numerical discrepancy
between patient and observer derived joint counts (0.30
+ 0.46), showing that patients in a good disease activity
state were able to assess their disease activity as accu-
rately as an expert evaluator, likely because in a good
clinical state there is less room for a numerical error.
Consequently, patients who rated themselves as being in
remission by using their joint counts for definitions of
remission had a high positive predictive value to be
effectively in remission according to the new ACR/
EULAR remission definitions. In this group of patients
self derived assessment of disease activity seems to be a
reliable and valid tool and, therefore, less frequent physi-
cian contacts would be feasible. These findings were
independent of potential confounders, such as disease
duration, pain or functional disability.
A simple training session did not substantially improve
the agreement of patient and observer derived joint
counts. While this may be surprising at first sight, there is
evidence that even among trained health professionals
with experience in assessing joints a substantial variation
occurs [14,15]. Thus, our data suggest that there is not
much benefit of formal training; nevertheless, it may be
useful to instruct patients on the distinction between
inflammatory and non-inflammatory joint swelling.
One strength of our study is the focus on real life
patients with a broad range of disease activity and disease
duration reflecting daily routine situations. This allowed
us to investigate the main hypothesis of the present
study, whether the reliability of patient-reported joint
counts, which is viewed controversially in the literature,
would be more convincing in low disease activity or
remission than generally. Since these low disease activity
states are now the treatment targets in RA [7,16], one
would hope to see increasing numbers of patients in
these good states. By having patients themselves assess
the persistent absence of joint swelling the tight control
concept could be further strengthened without over-
whelming the available resources. This is also important
in terms of pain as in low disease activity and remission
patients frequently have no pain. If so, patient should be
able to distinguish whether pain is due to swelling and
‘flair’ of RA and, therefore, call a rheumatologist or if
pain is due to other problems one should visit their
family doctor instead. On the other hand, the data pre-
sented also reveal that at higher states of disease activity
major discrepancies can be discerned between patient
and trained assessor derived joint counts. The high
Table 3 Agreement of patient defined remission with remission according to the ACR-EULAR definitions using the
traditional evaluator derived joint counts (REF) (’gold standard’).





















Patients in REM N = 25 N = 34 N = 22 N = 28 N = 30 37 32 37
Patients not in
REM
n = 171 N = 175 N = 177 N = 181 N = 147 172 164 172
Positive
Predictive Value
0.74 0.71 0.81 0.86
Negative
Predictive Value
0.98 0.98 0.85 0.95
CDAI, clinical disease activity index; REM, remission; SDAI, simplified disease activity index.
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agreement in joint counts obtained by physicians and
biometricians with similar disagreement compared with
patient derived joint counts indicates that, with active
disease, visits to a rheumatologist are indispensable.
Our study has several limitations. Firstly, the patient
population is derived from a single center and, there-
fore, it is not self-evident that the data presented can
be generalized. Ultimate proof or disproof will have to
come from studies performed in other cohorts. Sec-
ondly, the analyses performed, even if evaluating two
consecutive visits, were cross sectional in terms of
treatments since therapeutic changes were not studied
and consequent outcomes not assessed using patient
derived joint counts. Thirdly, a possible gold standard
related to the ‘truthfulness’ of patient versus assessor
performed joint counts, such as by sonography or
magnetic resonance imaging, was not performed and,
therefore, it is not clear which of the counts is nearer
to the ‘truth’, the presence or absence of synovial
inflammation. In our study, we used the biometrician
derived joint counts as a gold standard as they were
performed by a trained health professional who
assesses joints in daily routine. These joint counts are
used for composite scores at our clinics. Furthermore
we did not perform training sessions and assessed
accuracy as addressed by Gall et al. [17] which might
have improved the effect of training. Fourthly, joint
assessments by different investigators were not rando-
mized which might bias the results as showing con-
stantly higher or lower joint counts at different
assessments. Fifthly, since joint damage is correlated
with swollen joints [1,18,19] and we did not assess
radiographs, it is unclear which of the joint counts,
patient or assessor derived, is more closely related to
the progression of joint damage. These questions will
have to be addressed in future studies and form an
important research agenda.
Conclusions
Self-assessed joint counts by patients who are in clinical
remission are reliable and could be a useful tool in daily
clinical practice as they allow effective follow up without
need for tightly scheduled physician contacts. The data
indicate a better level of agreement in joint assessment by
patients in remission and with very low joint counts than
in patients with more active disease. Although patient’s
self-assessment seems to be less effective in active disease,
our data indicate that patients should be well able to con-
firm the maintenance of the previously observed state of
remission over time. Therefore, patient reported disease
activity should be incorporated in their daily routine for
patients who have reached good clinical states as this
could guide physicians in optimizing treatment strategies,
while patients’ self-performed joint counts in the presence
of high disease activity cannot replace clinical assessment
by the rheumatologist which, in these situations, therefore
is indispensable.
Abbreviations
ACR: American College of Rheumatology; CDAI: clinical disease activity index;
CRP: C-reactive protein; DAS28: disease activity index 28 joints; EGA:
evaluator global assessment of disease activity; ESR: erythrocyte
sedimentation rate; EULAR: European League against Rheumatism; HAQ:
health assessment questionnaire; HDA: high disease activity; ICC: intraclass
correlation coefficient; MCP: metacarpo-phalangeal joint; MDA: moderate
disease activity; LDA: low disease activity; PGA: patient global assessment of
disease activity; PIP: proximal interphalangeal joint; RA: rheumatoid arthritis;
REM: remission; SDAI: simplified disease activity index; SJC: swollen joint
count; TJC: tender joint count; VAS: visual analogue scale.
Acknowledgements
The authors thank Michaela Ernst, the biometrician of the department of
rheumatology, who performed joint counts on our patients.
Authors’ contributions
HR gave training sessions to the patients, performed joint counts, made
statistical analyses, and wrote the first draft of the manuscript. JG, JS, TS and
DA contributed to the final version of the manuscript by providing
comments and suggestions on the statistical analyses and draft version of
the manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 9 October 2011 Revised: 3 January 2012
Accepted: 14 March 2012 Published: 14 March 2012
References
1. Lukas C, van der Heijde D, Fatenajad S, Landewe R: Repair of erosions
occurs almost exclusively in damaged joints without swelling. Ann
Rheum Dis 2010, 69:851-855.
2. Smolen JS, Van Der Heijde DM, St Clair EW, Emery P, Bathon JM,
Keystone E, Maini RN, Kalden JR, Schiff M, Baker D, Han C, Han J, Bala M:
Predictors of joint damage in patients with early rheumatoid arthritis
treated with high-dose methotrexate with or without concomitant
infliximab: results from the ASPIRE trial. Arthritis Rheum 2006, 54:702-710.
3. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, Kincaid W,
Porter D: Effect of a treatment strategy of tight control for rheumatoid
arthritis (the TICORA study): a single-blind randomised controlled trial.
Lancet 2004, 364:263-269.
4. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-
Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L,
Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-
Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van
Riel P, Scholte M, Scott DL, Sokka T, Valesini G, et al: EULAR
recommendations for the management of rheumatoid arthritis with
synthetic and biological disease-modifying antirheumatic drugs. Ann
Rheum Dis 2010, 69:964-975.
5. Radner H, Aletaha D, Smolen JS: Work productivity, quality of life, and
health states of different disease activity states in patients with
rheumatoid arthritis (RA) [abstract]. Ann Rheum Dis 2009, 68(Suppl3):396.
6. Radner H, Aletaha D, Smolen JS: Achievement of remission - a socio-
economic point of view [abstract]. Ann Rheum Dis 2010, 69(Suppl3):494.
7. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, Aletaha D,
Allaart CF, Bathon J, Bombardieri S, Brooks P, Brown A, Matucci-Cerinic M,
Choi H, Combe B, de Wit M, Dougados M, Emery P, Furst D, Gomez-
Reino J, Hawker G, Keystone E, Khanna D, Kirwan J, Kvien TK, Landewe R,
Listing J, Michaud K, Martin-Mola E, Montie P, et al: American College of
Rheumatology/European League against Rheumatism provisional
definition of remission in rheumatoid arthritis for clinical trials. Ann
Rheum Dis 2011, 70:404-413.
8. Van der Bijl AE, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ten Wolde S,
Han KH, van Krugten MV, Allaart CF, Breedveld FC, Dijkmans BA: Infliximab
Radner et al. Arthritis Res Ther 2012, 14:R61
http://arthritis-research.com/content/14/2/R61
Page 8 of 9
and methotrexate as induction therapy in patients with early
rheumatoid arthritis. Arthritis Rheum 2007, 56:2129-2134.
9. Figueroa F, Braun-Moscovici Y, Khanna D, Voon E, Gallardo L, Luinstra D,
Pina X, Henstorf G, Laurence S, Neiman R, Furst D: Patient self-
administered joint tenderness counts in rheumatoid arthritis are reliable
and responsive to changes in disease activity. J Rheumatol 2007, 34:54-56.
10. Houssien DA, Stucki G, Scott DL: A patient-derived disease activity score
can substitute for a physician-derived disease activity score in clinical
research. Rheumatology (Oxford) 1999, 38:48-52.
11. Kavanaugh A, Lee SJ, Weng HH, Chon Y, Huang XY, Lin SL: Patient-derived
joint counts are a potential alternative for determining Disease Activity
Score. J Rheumatol 2010, 37:1035-1041.
12. Voon E, Phan L, Ruttkay D, Madera X, Mcateer A, Neely K, Laurence S,
Smith A, Mullen BJ, Neiman R, Furst DE: Patient self-administered joint
tenderness and swelling counts in RA are reliable and responsive to
therapy. Arthritis Rheum 1997, 40:1530.
13. Katchamart W, Bombardier C: Systematic monitoring of disease activity
using an outcome measure improves outcomes in rheumatoid arthritis.
J Rheumatol 2010, 37:1411-1415.
14. Salaffi F, Filippucci E, Carotti M, Naredo E, Meenagh G, Ciapetti A, Savic V,
Grassi W: Inter-observer agreement of standard joint counts in early
rheumatoid arthritis: a comparison with grey scale ultrasonography–a
preliminary study. Rheumatology (Oxford) 2008, 47:54-58.
15. Scott DL, Choy EH, Greeves A, Isenberg D, Kassinor D, Rankin E, Smith EC:
Standardising joint assessment in rheumatoid arthritis. Clin Rheumatol
1996, 15:579-582.
16. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G,
Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-
Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-
Mola E, Montecucco C, Schoels M, van der Heijde D: Treating rheumatoid
arthritis to target: recommendations of an international task force. Ann
Rheum Dis 2010, 69:631-637.
17. Gall EP, Meredith KE, Stillman PL, Rutala PJ, Gooden MA, Boyer JT, Riggs GE:
The use of trained patient instructors for teaching and assessing
rheumatologic care. Arthritis Rheum 1984, 27:557-563.
18. Kirwan JR: The relationship between synovitis and erosions in
rheumatoid arthritis. Br J Rheumatol 1997, 36:225-228.
19. Van der Heide A, Remme CA, Hofman DM, Jacobs JW, Bijlsma JW:
Prediction of progression of radiologic damage in newly diagnosed
rheumatoid arthritis. Arthritis Rheum 1995, 38:1466-1474.
doi:10.1186/ar3777
Cite this article as: Radner et al.: Value of self-performed joint counts in
rheumatoid arthritis patients near remission. Arthritis Res Ther 2012 14:
R61.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Radner et al. Arthritis Res Ther 2012, 14:R61
http://arthritis-research.com/content/14/2/R61
Page 9 of 9
